{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T10:27:42Z","timestamp":1778840862398,"version":"3.51.4"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,7,3]],"date-time":"2013-07-03T00:00:00Z","timestamp":1372809600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s12253-013-9658-5","type":"journal-article","created":{"date-parts":[[2013,7,2]],"date-time":"2013-07-02T08:02:49Z","timestamp":1372752169000},"page":"61-66","source":"Crossref","is-referenced-by-count":6,"title":["Clinical Outcome of Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph + ALL): Experience From a Single Institution"],"prefix":"10.1007","volume":"20","author":[{"given":"Noriko","family":"Doki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuteru","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaku","family":"Oshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Kakihana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"Sakamaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,7,3]]},"reference":[{"key":"9658_CR1","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1182\/blood.V99.5.1536","volume":"99","author":"B Gleissner","year":"2002","unstructured":"Gleissner B, Gokbuget N, Bartram CR et al (2002) Leading prognostic relevance of the BCR-ABLtranslocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German Multicenter Traial Group and confirmed polymerase chain reaction analysis. Blood 99:1536\u20131543","journal-title":"Blood"},{"key":"9658_CR2","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1182\/blood-2006-10-052746","volume":"109","author":"M Vinetti","year":"2007","unstructured":"Vinetti M, Fazi P, Cimino G et al (2007) Imatinib plus steroids induces complete remissons and prolonged survival in elderly Philadelphia chromosome-positive patients with acute lymphoblastic leukemia without additional chemotherapy:results of the Gruppo Italiano Malattie Ematologiche dell\u2019Adulto (GI-MEMA) LAL0201-B protocol. Blood 109:3676\u20133678","journal-title":"Blood"},{"key":"9658_CR3","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1182\/blood-2004-09-3785","volume":"105","author":"S Lee","year":"2005","unstructured":"Lee S, Kim YJ, Min CK et al (2005) The effect of first-line imatinib interim therapy on the outcome of allogeneic stem cell transplantation in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 105:3449\u20133457","journal-title":"Blood"},{"key":"9658_CR4","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/cncr.25690","volume":"117","author":"HJ Lee","year":"2011","unstructured":"Lee HJ, Thompson JE, Wang ES et al (2011) Philadelphia chromosome-positive acute lymphoblastic leukemia: current treatment and future perspectives. Cancer 117:1583\u20131594","journal-title":"Cancer"},{"key":"9658_CR5","first-page":"867","volume":"26","author":"M Yanada","year":"2005","unstructured":"Yanada M, Naoe T, Iida H et al (2005) Myeloablative allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adults: significant roles of total body irradiation and chronic graft-versus-host disease. BMT 26:867\u2013872","journal-title":"BMT"},{"key":"9658_CR6","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.bbmt.2011.08.011","volume":"18","author":"P Kebriaei","year":"2012","unstructured":"Kebriaei P, Saliba R, Rondon G et al (2012) Long-term follow-up of allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: impact of tyrosine kinase inhibitors on treatment outcomes. Biol Blood Marrow Transplant 18:584\u2013592","journal-title":"Biol Blood Marrow Transplant"},{"key":"9658_CR7","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1182\/blood-2009-01-199380","volume":"113","author":"AK Fielding","year":"2009","unstructured":"Fielding AK, Rowe JM, Richards SM et al (2009) Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII\/ECOG 2993. Blood 113:4489\u20134496","journal-title":"Blood"},{"key":"9658_CR8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/leu.2010.228","volume":"25","author":"S Mizuta","year":"2011","unstructured":"Mizuta S, Matsuo K, Yagasaki F et al (2011) Pre-transplant imatinib-based therapy improves the outcome of allogeneic hematopoietic stem cell transplantation for BCR-ABL-positive acute lymphoblastic leukemia. Leukemia 25:41\u201347","journal-title":"Leukemia"},{"key":"9658_CR9","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1038\/bcj.2012.18","volume":"2","author":"S Mizuta","year":"2012","unstructured":"Mizuta S, Matsuo K, Maeda T et al (2012) Prognostic factors influencing clinical outcome of allogeneic hematopoietic stem cell transplantation following imatinib-based therapy in BCR-ABL-positive ALL. Blood Cancer J 2:e72","journal-title":"Blood Cancer J"},{"key":"9658_CR10","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3324\/haematol.10965","volume":"92","author":"O Spinelli","year":"2007","unstructured":"Spinelli O, Peruta B, Tosi M et al (2007) Clearance of minimal residual disease after allogeneic stem cell transplantation and the prediction of the clinical outcome of adult patints with high-risk acute lymphoblastic leukemia. Haematologica 92:612\u2013618","journal-title":"Haematologica"},{"key":"9658_CR11","first-page":"107","volume":"43","author":"MJ Burke","year":"2009","unstructured":"Burke MJ, Troz B, Baker KS et al (2009) Allo-hematopoietic cell transplantation for Ph chromosome-positive ALL: impact of imatinib on relapse and survival. BMT 43:107\u2013113","journal-title":"BMT"},{"key":"9658_CR12","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1182\/blood-2006-04-019836","volume":"109","author":"PA Carpenter","year":"2007","unstructured":"Carpenter PA, Snyder DS, Flowers ME et al (2007) Prophilactic administration of imatinib after hematopoietic cell transplantation for high-risk Philadelphia chromosome-positive leukemia. Blood 109:2791\u20132793","journal-title":"Blood"},{"key":"9658_CR13","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1158\/0008-5472.CAN-05-0259","volume":"65","author":"T O\u2019Hare","year":"2005","unstructured":"O\u2019Hare T, Walters DK, Stoffregen EP et al (2005) In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutants. Cancer Res 65:4500\u20134505","journal-title":"Cancer Res"},{"key":"9658_CR14","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1182\/blood-2009-12-261586","volume":"116","author":"F Ravandi","year":"2010","unstructured":"Ravandi F, O\u2019Brein S, Thomas D et al (2010) First report of phase 2 study of dasatinib with hyper-CVAD for the frontline treatment of patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia. Blood 116:2070\u20132077","journal-title":"Blood"},{"key":"9658_CR15","doi-asserted-by":"crossref","first-page":"6521","DOI":"10.1182\/blood-2011-05-351403","volume":"118","author":"R Foa","year":"2011","unstructured":"Foa R, Vitale A, Vifnwrri M et al (2011) Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 118:6521\u20136528","journal-title":"Blood"},{"key":"9658_CR16","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.bbmt.2011.12.587","volume":"18","author":"G Caocci","year":"2012","unstructured":"Caocci G, Vacca A, Ledda A et al (2012) Prophylactic and preemptive therapy with dasatinib after hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. Biol Blood Marrow Transplant 18:652\u2013654","journal-title":"Biol Blood Marrow Transplant"},{"key":"9658_CR17","author":"CL Teng","year":"2013","unstructured":"Teng CL, Yu JT, Chen HC, Hwang WL (2013) Maintenance therapy with dasatinib after allogeneic hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia. Ann Hematol. doi: 10.1007\/s00277\u2212012-1670-4","journal-title":"Ann Hematol"}],"container-title":["Pathology & Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-013-9658-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12253-013-9658-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-013-9658-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T13:54:52Z","timestamp":1596030892000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12253-013-9658-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,3]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["9658"],"URL":"https:\/\/doi.org\/10.1007\/s12253-013-9658-5","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"value":"1219-4956","type":"print"},{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,3]]}}}